Humphrey visual field analyser

Last updated
Figure 1 - Humphrey field analyser Humphrey visual field.JPG
Figure 1 - Humphrey field analyser

Humphrey field analyser (HFA) is a tool for measuring the human visual field that is commonly used by optometrists, orthoptists and ophthalmologists, particularly for detecting monocular visual field. [1]

Contents

The results of the analyser identify the type of vision defect. Therefore, it provides information regarding the location of any disease processes or lesion(s) throughout the visual pathway. This guides and contributes to the diagnosis of the condition affecting the patient's vision. These results are stored and used for monitoring the progression of vision loss and the patient's condition. [2]

Medical uses

The analyser can be used for screening, monitoring and assisting in the diagnosis of certain conditions. There are numerous testing protocols to select, based on the purpose. The first number denotes the extent of the field measured on the temporal side, from the centre of fixation, in degrees. The '-2' represents the pattern of the points tested. [3] They include:

The above tests can be performed in either SITA-Standard or SITA-Fast. SITA-Fast is a quicker method of testing. It produces similar results compared to SITA-Standard, however repeatability is questionable and it is slightly less sensitive [8] [9]

There are additional tests for more specific purposes such as the following:

Method of assessment

Figure 2 - Chin Rest and Lens Holder Trial lens.png
Figure 2 - Chin Rest and Lens Holder

The analyser test takes approximately 5–8 minutes, excluding patient set up. There are multiple steps which need to be done before commencement of the test to ensure reliable results are attained.

The test type and eye are firstly selected and the patient's details are entered, including their refractive error. The analyser will provide a lens strength and type (either spherical and/or cylindrical), if required for the test. In these instances, wire-rimmed trial lenses are generally used, with the cylindrical lens placed closest to the patient so the axis is easily read. The clinician can alter the fixation targets as per necessary (see Fixation Targets for advice). [12]

Before putting the patient onto the machine, the patient is instructed to maintain fixation on the central target and is given a buzzer to only press when they see a light stimulus. It is not possible to see every light and some lights appear brighter/duller and slower/faster than others. The eye not being tested is patched and the room lights are dimmed prior to commencement of the test. [12]

The patient is positioned appropriately and comfortably against the forehead rest and chin rest. Minor adjustments to the head position are made to centre the pupil on the display screen to allow eye monitoring throughout the test. The lens holder should be as close to the patient's eye as possible to avoid artefacts (see Disadvantages for possible artefacts).

It is important for the patient to blink normally, relax and maintain concentration throughout the test. This will increase the reliability of results. [12]

Figure 3 - Fixation targets left: central, middle: small diamond, right: large diamond Fixation targets.jpg
Figure 3 - Fixation targets left: central, middle: small diamond, right: large diamond

How it works

The analyser projects a series of white light stimuli of varying intensities (brightness), throughout a uniformly illuminated bowl. The patient uses a handheld button that they press to indicate when they see a light. This assesses the retina's ability to detect a stimulus at specific points within the visual field. This is called retinal sensitivity and is recorded in 'decibels' (dB). [1]

The analyser currently utilises the Swedish Interactive Thresholding Algorithm (SITA); a formula which allows the fastest and most accurate visual field assessment to date. Results are then compared against an age-matched database which highlights unusual and suspicious vision loss, potentially caused by pathology. [8]

Fixation targets

There are different targets a patient can fixate on during the test. They are chosen on the basis of the patient's conditions. [12]


Interpreting results

Reliability indices

Issues of reliability are critical in result interpretation. These include, but not limited to, the patient losing concentration, closing their eyes or pressing the buzzer too frequently. Monitoring fixation is made visible via the display screen and gaze tracker, located at the bottom of the printout. The degree of reliability is determined by the reliability indices located on the printout (Fig. 4). These are assessed first and allow the examiner to determine if the end results are reliable. These indices include:

Plots

Figure 4 - Analyser Printout
1: Reliability Indices
2: Numerical Display
3: Grey Scale
4: Total Deviation
5: Probability Display
6: Pattern Deviation
7: Global Indices
8: Glaucoma Hemifield Test
9: Visual Field Index Plots2.jpg
Figure 4 - Analyser Printout
1: Reliability Indices
2: Numerical Display
3: Grey Scale
4: Total Deviation
5: Probability Display
6: Pattern Deviation
7: Global Indices
8: Glaucoma Hemifield Test
9: Visual Field Index

After reliability is determined, the remaining data is assessed.

Numerical display

The numerical display represents raw values of patient's retinal sensitivity at specific retinal points in dB. Higher numbers equate to higher retinal sensitivities. Sensitivity is greatest in the central field and decreases towards the periphery. Normal values are approximately 30 dB while recorded values of <0 dB equate to no sensitivity measured. [16]

Grey scale

The grey scale is a graphical representation of the numerical display, allowing for easy interpretation of the field loss. Lower sensitivities are indicated by darker areas and higher sensitivities are represented with a lighter tone. [3] This scale is used to demonstrate vision changes to the patient but is not used for diagnostic purposes.

Total deviation

The numerical total demonstrates the difference between measured values and population age-norm values at specific retinal points. [3]

  • Negative values indicate lower than normal sensitivity
  • Positive indicates higher
  • 0 equals no change [3]

The statistical display (located below the numerical total) demonstrates the percentage of the normal population who measure below the patient's value at a specific retinal point. The probability display provides this percentage a key for interpreting the statistical display. [3] For example, the darkest square in the key represents that <0.5% of the population would also attain this result, indicating that the vision loss is extensive. The total deviation plots highlight diffuse vision loss (i.e. the total departure from the age-norm). [17]

Pattern deviation

The pattern deviation provides a numerical total and statistical display as the total deviation plot. However, it accounts for general reductions of vision caused by media opacities (e.g. cataract), uncorrected refractive error, reductions in sensitivity due to age and pupil miosis. This highlights focal loss only (i.e. vision loss suspected from only pathological processes). [16] Therefore, this is the main plot referred to when making a diagnosis. The pattern deviation plot is generally lighter than the total deviation because of the factors accounted for.

Global indices

Figure 5 - Types of Visual Field Defects (right eye)
A: Central scotoma
B: Centrocaecal scotoma
C: Nasal Step
D: Superior Arcuate
E: Nasal Wedge defect
F: Superior Nasal quadrantanopia
G: Superior Altitudinal
H: Nasal hemianopia
I: Enlarged Blind Spot with Paracentral scotoma located 15 degrees superiorly Visual-field-loss.pdf
Figure 5 - Types of Visual Field Defects (right eye)
A: Central scotoma
B: Centrocaecal scotoma
C: Nasal Step
D: Superior Arcuate
E: Nasal Wedge defect
F: Superior Nasal quadrantanopia
G: Superior Altitudinal
H: Nasal hemianopia
I: Enlarged Blind Spot with Paracentral scotoma located 15 degrees superiorly

These provide a statistical summary of the field with one number. Although not used for initial diagnosis, they are essential for monitoring glaucoma progression. [3] They include:

  • Mean deviation (MD): Derived from the total deviation and represents the overall mean departure from the age-corrected norm. [18] A negative value indicates field loss, while a positive value indicates that the field is above average. A P value is provided if the global indices are abnormal. It provides a statistical representation of the population. For example, P <2% means that less than 2% of the population have vision loss worse than measured [19]
  • Pattern standard deviation (PSD): Derived from the pattern deviation and thus highlights focal loss only. A high PSD, indicating irregular vision, is therefore a more useful indicator of glaucomatous progression, than the MD [3]

Glaucoma hemifield test

The glaucoma hemifield test (GHT) provides assessment of the visual field where glaucomatous damage is often seen. It compares five corresponding and mirrored areas in the superior and inferior visual fields. [3] [20] The result of either 'Outside Normal Limits' (significant difference in superior and inferior fields), 'Borderline' (suspicious differences) or 'Within Normal Limits' (no differences) is only considered when the patient has, or is a suspect for, glaucoma. [20] This is only available in 30-2 and 24-2 analyser protocol. [3]

Visual field index

The visual field index (VFI) reflects retinal ganglion cell loss and function, as a percentage, with central points weighted more. [21]

It is expressed as a percentage of visual function; with 100% being a perfect age-adjusted visual field and 0% represents a perimetrically blind field. The pattern deviation probability plot (or total deviation probability plot when MD is worse than -20 dB) is used to identify abnormal points and age corrected sensitivity at each point is calculated using total deviation numerical map. VFI is a reliable index on which glaucomatous visual field severity staging can be based. [22]

The shaded pattern of vision loss provided on the pattern deviation plot allows for diagnosis of the type of vision loss present. This contributes to other clinical findings in the diagnosis of certain conditions. The types of vision loss and associated conditions are not described in the extent of this article, however Figure 5 provides typical examples of visual field loss seen. Refer to #See also for more information.

Advantages and disadvantages

Advantages

Disadvantages

See also

Related Research Articles

<span class="mw-page-title-main">Glaucoma</span> Group of eye diseases

Glaucoma is a group of eye diseases that lead to damage of the optic nerve, which transmits visual information from the eye to the brain. Glaucoma may cause vision loss if left untreated. It has been called the "silent thief of sight" because the loss of vision usually occurs slowly over a long period of time. A major risk factor for glaucoma is increased pressure within the eye, known as intraocular pressure (IOP). It is associated with old age, a family history of glaucoma, and certain medical conditions or medications. The word glaucoma comes from the Ancient Greek word γλαυκóς, meaning 'gleaming, blue-green, gray'.

<span class="mw-page-title-main">Optic nerve</span> Second cranial nerve, which connects the eyes to the brain

In neuroanatomy, the optic nerve, also known as the second cranial nerve, cranial nerve II, or simply CN II, is a paired cranial nerve that transmits visual information from the retina to the brain. In humans, the optic nerve is derived from optic stalks during the seventh week of development and is composed of retinal ganglion cell axons and glial cells; it extends from the optic disc to the optic chiasma and continues as the optic tract to the lateral geniculate nucleus, pretectal nuclei, and superior colliculus.

<span class="mw-page-title-main">Peripheral vision</span> Area of ones field of vision outside of the point of fixation

Peripheral vision, or indirect vision, is vision as it occurs outside the point of fixation, i.e. away from the center of gaze or, when viewed at large angles, in the "corner of one's eye". The vast majority of the area in the visual field is included in the notion of peripheral vision. "Far peripheral" vision refers to the area at the edges of the visual field, "mid-peripheral" vision refers to medium eccentricities, and "near-peripheral", sometimes referred to as "para-central" vision, exists adjacent to the center of gaze.

The visual field is "that portion of space in which objects are visible at the same moment during steady fixation of the gaze in one direction"; in ophthalmology and neurology the emphasis is on the structure inside the visual field and it is then considered “the field of functional capacity obtained and recorded by means of perimetry”.

<span class="mw-page-title-main">Intraocular pressure</span> Fluid pressure inside the eye

Intraocular pressure (IOP) is the fluid pressure inside the eye. Tonometry is the method eye care professionals use to determine this. IOP is an important aspect in the evaluation of patients at risk of glaucoma. Most tonometers are calibrated to measure pressure in millimeters of mercury (mmHg).

<span class="mw-page-title-main">Amsler grid</span> Tool to detect defects in central vision

The Amsler grid, used since 1945, is a grid of horizontal and vertical lines used to monitor a person's central visual field. The grid was developed by Marc Amsler, a Swiss ophthalmologist. It is a diagnostic tool that aids in the detection of visual disturbances caused by changes in the retina, particularly the macula, as well as the optic nerve and the visual pathway to the brain. Amsler grid usually help detecting defects in central 20 degrees of the visual field.

Meridian is used in perimetry and in specifying visual fields. According to IPS Perimetry Standards 1978 (2002): "Perimetry is the measurement of [an observer's] visual functions ... at topographically defined loci in the visual field. The visual field is that portion of the external environment of the observer [in which when he or she is] steadily fixating ...[he or she] can detect visual stimuli."

<span class="mw-page-title-main">Metamorphopsia</span> Type of vision distortion

Metamorphopsia is a type of distorted vision in which a grid of straight lines appears wavy and parts of the grid may appear blank. People can first notice they suffer with the condition when looking at mini-blinds in their home. For example, straight lines might be wavy or bendy. Things may appear closer or further than they are.

<span class="mw-page-title-main">Visual field test</span> Eye examination that can detect dysfunction in central and peripheral vision

A visual field test is an eye examination that can detect dysfunction in central and peripheral vision which may be caused by various medical conditions such as glaucoma, stroke, pituitary disease, brain tumours or other neurological deficits. Visual field testing can be performed clinically by keeping the subject's gaze fixed while presenting objects at various places within their visual field. Simple manual equipment can be used such as in the tangent screen test or the Amsler grid. When dedicated machinery is used it is called a perimeter.

Stargardt disease is the most common inherited single-gene retinal disease. In terms of the first description of the disease, it follows an autosomal recessive inheritance pattern, which has been later linked to bi-allelic ABCA4 gene variants (STGD1). However, there are Stargardt-like diseases with mimicking phenotypes that are referred to as STGD3 and STGD4, and have a autosomal dominant inheritance due to defects with ELOVL4 or PROM1 genes, respectively. It is characterized by macular degeneration that begins in childhood, adolescence or adulthood, resulting in progressive loss of vision.

The Swedish interactive thresholding algorithm, usually referred to as SITA, is a method to test for visual field loss, usually in glaucoma testing or monitoring. It is combined with a visual field test such as standard automated perimetry (SAP) or short wavelength automated perimetry (SWAP) to determine visual fields in a more efficient manner.

<span class="mw-page-title-main">Blurred vision</span> Medical condition

Blurred vision is an ocular symptom where vision becomes less precise and there is added difficulty to resolve fine details.

Jannik Petersen Bjerrum was a Danish ophthalmologist who was a native of Skærbæk, a town in the southernmost part of Jutland. In 1864 Skærbæk became part of Germany due to consequences of the Second Schleswig War.

The frequency-doubling illusion is an apparent doubling of spatial frequency when a sinusoidal grating is modulated rapidly in temporal counterphase. Recently, it has been proposed that the illusion arises from a spatially nonlinear ganglion cell class. The contrast threshold values needed for perceiving this physiological effect are used in frequency doubling technology perimetry for the detection of even early phases of glaucoma. A more recent study's results argue against the hypothesis that spatially nonlinear retinal ganglion cells are the physiological substrate of the frequency-doubling illusion. A cortical pathway of temporal phase discrimination may be the principal cause of the illusion, whereas spatial phase information is retained.

Flammer syndrome is a described clinical entity comprising a complex of clinical features caused mainly by dysregulation of the blood supply. It was previously known as vascular dysregulation. It can manifest in many symptoms, such as cold hands and feet, and is often associated with low blood pressure. In certain cases it is associated with or predisposes to the development of diseases such as a normal tension glaucoma. Flammer syndrome is named after the Swiss ophthalmologist Josef Flammer.

<span class="mw-page-title-main">Josef Flammer</span>

Josef Flammer is a Swiss ophthalmologist and long-time director of the Eye Clinic at Basel University Hospital. Flammer is a glaucoma specialist who developed a new pathogenetic concept of glaucomatous damage according to which unstable blood supply leads to oxidative stress, which in turn plays a major role in apoptosis of cells in the optic nerve and retina in glaucoma patients.

Microperimetry, sometimes called fundus-controlled perimetry, is a type of visual field test which uses one of several technologies to create a "retinal sensitivity map" of the quantity of light perceived in specific parts of the retina in people who have lost the ability to fixate on an object or light source. The main difference with traditional perimetry instruments is that, microperimetry includes a system to image the retina and an eye tracker to compensate eye movements during visual field testing.

<span class="mw-page-title-main">Visual pathway lesions</span> Overview about the lesions of visual pathways

The visual pathway consists of structures that carry visual information from the retina to the brain. Lesions in that pathway cause a variety of visual field defects. In the visual system of human eye, the visual information processed by retinal photoreceptor cells travel in the following way:
Retina→Optic nerve→Optic chiasma →Optic tract→Lateral geniculate body→Optic radiation→Primary visual cortex

Megalopapilla is a non-progressive human eye condition in which the optic nerve head has an enlarged diameter, exceeding 2.1 mm with no other morphological abnormalities.

<span class="mw-page-title-main">Heidelberg Retinal Tomography</span>

The Heidelberg Retinal Tomography is a diagnostic procedure used in ophthalmology. The Heidelberg Retina Tomograph (HRT) is an ophthalmological confocal point scanning laser ophthalmoscope for examining the cornea and certain areas of the retina using different diagnostic modules. However, the most widely used area of application for HRT is the inspection of the optic nerve head (papilla) for early detection and follow-up of glaucoma. The procedure has established itself as an integral part of routine glaucoma diagnostics alongside the visual field examination (perimetry), the chamber angle examination (gonioscopy) and the measurement of intraocular pressure (tonometry). The HRT is the most widely used application of confocal scanning laser ophthalmoscopy.

References

  1. 1 2 Landers, John; Sharma, Alok; Goldberg, Ivan; Graham, Stuart L (February 2010). "A comparison of visual field sensitivities between the Medmont automated perimeter and the Humphrey field analyzer". Clinical & Experimental Ophthalmology. 38 (3): 273–276. doi:10.1111/j.1442-9071.2010.02246.x. PMID   20447123. S2CID   9446504.
  2. Kedar, Sachin; Ghate, Deepta; Corbett, JamesJ (2011). "Visual fields in neuro-ophthalmology". Indian Journal of Ophthalmology. 59 (2): 103–109. doi: 10.4103/0301-4738.77013 . PMC   3116538 . PMID   21350279.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 Kanski, J. J.; Bowling, B. (2011). Clinical Ophthalmology. Edinburgh: Elsevier Saunders.
  4. Asaoka, Ryo; Vavvas, Demetrios (20 June 2014). "Mapping Glaucoma Patients' 30-2 and 10-2 Visual Fields Reveals Clusters of Test Points Damaged in the 10-2 Grid That Are Not Sampled in the Sparse 30-2 Grid". PLOS ONE. 9 (6): e98525. Bibcode:2014PLoSO...998525A. doi: 10.1371/journal.pone.0098525 . PMC   4064971 . PMID   24950300.
  5. 1 2 Khoury, Johnny, M.; Donahue, Sean, P.; Lavin, Patric, J.; Tsai, James (1999). "Comparison of 24-2 and 30-2 Perimetry in Glaucomatous and Nonglaucomatous Optic Neuropathies". Journal of Neuro-Ophthalmology. 19 (2): 100–108. doi:10.1097/00041327-199906000-00004. PMID   10380130.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. 1 2 Nouri-Mahdavi, Kouros (December 2014). "Selecting visual field tests and assessing visual field deterioration in glaucoma". Canadian Journal of Ophthalmology. 49 (6): 497–505. doi:10.1016/j.jcjo.2014.10.002. PMID   25433738.
  7. Huang, Charles Q.; Carolan, James; Redline, Daniel; Taravati, Parisa; Woodward, Kimberly R.; Johnson, Chris A.; Wall, Michael; Keltner, John L. (1 March 2008). "Humphrey Matrix Perimetry in Optic Nerve and Chiasmal Disorders: Comparison with Humphrey SITA Standard 24-2". Investigative Ophthalmology & Visual Science. 49 (3): 917–23. doi:10.1167/iovs.07-0241. PMID   18326712.
  8. 1 2 Bengtsson, Boel; Olsson, Jonny; Heijl, Anders; Rootzén, Holger (27 May 2009). "A new generation of algorithms for computerized threshold perimetry, SITA". Acta Ophthalmologica Scandinavica. 75 (4): 368–375. doi: 10.1111/j.1600-0420.1997.tb00392.x . PMID   9374242.
  9. 1 2 Szatmáry, Gabriella (1 September 2002). "Can Swedish Interactive Thresholding Algorithm Fast Perimetry Be Used as an Alternative to Goldmann Perimetry in Neuro-ophthalmic Practice?". Archives of Ophthalmology. 120 (9): 1162–1173. doi:10.1001/archopht.120.9.1162. PMID   12215089.
  10. "Vic Driving Vision Standards". Optometry Australia. Archived from the original on 2016-04-18.
  11. "Visual impairment". VicRoads. State Government of Victoria. 2015. Archived from the original on 2019-02-28.
  12. 1 2 3 4 5 6 7 8 9 10 11 12 Artes, Paul H (2012). Humphrey Field Analyzer II-i series User Manual. Carl Zeiss Meditec.
  13. Bengtsson, B; Heijl, A (2000). "False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability?". Investigative Ophthalmology and Visual Science. 41 (8): 2201–2204. PMID   10892863.
  14. McKendrick, Allison M.; Denniss, Jonathan; Turpin, Andrew (August 2014). "Response times across the visual field: Empirical observations and application to threshold determination". Vision Research. 101: 1–10. doi: 10.1016/j.visres.2014.04.013 . PMID   24802595.
  15. Johnson, Chris A; Keltner, John L; Cello, Kimberly E; Edwards, Mary; Kass, Michael A; Gordon, Mae O; Budenz, Donald L; Gaasterland, Douglas E; Werner, Elliot (March 2002). "Baseline visual field characteristics in the ocular hypertension treatment study". Ophthalmology. 109 (3): 432–437. doi:10.1016/S0161-6420(01)00948-4. PMID   11874743.
  16. 1 2 Wyatt, Harry J.; Dul, Mitchell W.; Swanson, William H. (March 2007). "Variability of visual field measurements is correlated with the gradient of visual sensitivity". Vision Research. 47 (7): 925–936. doi:10.1016/j.visres.2006.12.012. PMC   2094527 . PMID   17320924.
  17. Cubbidge, R (2012). "Essentials of visual field assessment". The Optician. 243 (6356): 14–16. ProQuest   1027770159.
  18. Chen, Yi-Hao; Wu, Jian-Nan; Chen, Jiann-Torng; Lu, Da-Wen (2008). "Comparison of the Humphrey Field Analyser and Humphrey Matrix Perimeter for the Evaluation of Glaucoma Patients". Ophthalmologica. 222 (6): 400–407. doi:10.1159/000154203. PMID   18781091. S2CID   38153319.
  19. Stamper, Robert L; Lieberman, Marc F; Drake, Michael V (2009). Becker-Shaffer's diagnosis and therapy of the glaucomas (8th ed.). [Edinburgh]: Mosby/Elsevier. ISBN   978-0-323-02394-8.
  20. 1 2 Ishiyama, Y.; Murata, H.; Mayama, C.; Asaoka, R. (11 November 2014). "An Objective Evaluation of Gaze Tracking in Humphrey Perimetry and the Relation With the Reproducibility of Visual Fields: A Pilot Study in Glaucoma". Investigative Ophthalmology & Visual Science. 55 (12): 8149–8152. doi:10.1167/iovs.14-15541. PMID   25389198.
  21. Horton, M. (2015). "10 tips for improving visual fields: perimetry may seem like second nature, but these recommendations can help you obtain better results by refining your understanding of the technology" . Review of Optometry. 152 (4): 62.
  22. Kuzhuppilly N, Patil S, Dev S, Deo A. Reliability of Visual Field Index in Staging Glaucomatous Visual Field Damage. Journal of Clinical & Diagnostic Research. 2018 Jun 1;12(6): NC05-NC08
  23. Saigal, Rahul. "Learning Effects and Artefacts in Automated Perimetry" (PDF). Association Of Optometry Ireland. Archived from the original (PDF) on 2015-10-04. Retrieved 2015-09-21.
  24. Donahue, Sean. P. (1998). "Lens Holder Artifact Simulating Glaucomatous Defect in Automated Perimetry". JAMA Ophthalmology. 116 (12): 1681–1683. doi:10.1001/archopht.116.12.1681. PMID   9869806.